HOTAIR rs7958904 polymorphism is associated with increased cervical cancer risk in a Chinese population. 2017

Hua Jin, and Xiaoyun Lu, and Jing Ni, and Jinfang Sun, and Bin Gu, and Bo Ding, and Haixia Zhu, and Chao Ma, and Mengjing Cui, and Yuling Xu, and Zhengdong Zhang, and Martin Lercher, and Jian Chen, and Na Gao, and Shizhi Wang
The Immunology Laboratory, Affiliated Tumor Hospital of Nantong University (Nantong Tumor Hospital), Nantong, China.

Previously, we have identified single nucleotide polymorphisms (SNPs) rs7958904 and rs4759314 in long non-coding RNA HOX transcript antisense RNA (HOTAIR) were significantly associated with risk of colorectal and gastric cancer, respectively. Here, we aimed to investigate the association between HOTAIR SNPs and cervical cancer (CC) susceptibility. A total of 1209 cases and 1348 controls were enrolled for association study and genotyped with TaqMan allelic discrimination method. The Cancer Genome Atlas (TCGA) database was utilized for in vivo analysis of allele-specific HOTAIR expression. MTT assay was employed for evaluation of allele-specific cell proliferation. The rs7958904 CC genotype was related to an increased risk of cervical cancer compared with the GG/GC genotypes (OR = 1.57, 95% CI = 1.10-2.25). TCGA database showed the CC tissues with rs7958904 CC genotype had higher HOTAIR expression than those with GG genotype (P = 0.046). MTT assay demonstrated a growth-promoting role of rs7958904 C allele on CC cells. Further functional studies on the effect of rs7958904 on biological behavior of CC cells are needed to confirm and extend our findings. In conclusion, HOTAIR rs7958904 might influence CC susceptibility through modulation of CC cell proliferation, and could serve as a diagnostic biomarker.

UI MeSH Term Description Entries
D002583 Uterine Cervical Neoplasms Tumors or cancer of the UTERINE CERVIX. Cancer of Cervix,Cancer of the Cervix,Cancer of the Uterine Cervix,Cervical Cancer,Cervical Neoplasms,Cervix Cancer,Cervix Neoplasms,Neoplasms, Cervical,Neoplasms, Cervix,Uterine Cervical Cancer,Cancer, Cervical,Cancer, Cervix,Cancer, Uterine Cervical,Cervical Cancer, Uterine,Cervical Cancers,Cervical Neoplasm,Cervical Neoplasm, Uterine,Cervix Neoplasm,Neoplasm, Cervix,Neoplasm, Uterine Cervical,Uterine Cervical Cancers,Uterine Cervical Neoplasm
D002681 China A country spanning from central Asia to the Pacific Ocean. Inner Mongolia,Manchuria,People's Republic of China,Sinkiang,Mainland China
D005091 Exons The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA. Mini-Exon,Exon,Mini Exon,Mini-Exons
D005260 Female Females
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016022 Case-Control Studies Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time. Case-Base Studies,Case-Comparison Studies,Case-Referent Studies,Matched Case-Control Studies,Nested Case-Control Studies,Case Control Studies,Case-Compeer Studies,Case-Referrent Studies,Case Base Studies,Case Comparison Studies,Case Control Study,Case Referent Studies,Case Referrent Studies,Case-Comparison Study,Case-Control Studies, Matched,Case-Control Studies, Nested,Case-Control Study,Case-Control Study, Matched,Case-Control Study, Nested,Case-Referent Study,Case-Referrent Study,Matched Case Control Studies,Matched Case-Control Study,Nested Case Control Studies,Nested Case-Control Study,Studies, Case Control,Studies, Case-Base,Studies, Case-Comparison,Studies, Case-Compeer,Studies, Case-Control,Studies, Case-Referent,Studies, Case-Referrent,Studies, Matched Case-Control,Studies, Nested Case-Control,Study, Case Control,Study, Case-Comparison,Study, Case-Control,Study, Case-Referent,Study, Case-Referrent,Study, Matched Case-Control,Study, Nested Case-Control
D044466 Asian People Persons having origins in any of the Asian racial groups of the Far East, Southeast Asia, or the Indian subcontinent including, for example, Cambodia, China, India, Japan, Korea, Malaysia, Pakistan, the Philippine Islands, Thailand, and Vietnam. Note that OMB category ASIAN is available for United States population groups. Race and ethnicity terms, as used in the federal government, are self-identified social construct and may include terms outdated and offensive in MeSH to assist users who are interested in retrieving comprehensive search results for studies such as in longitudinal studies. Asian Continental Ancestry Group,Asian Person,Asiatic Race,Mongoloid Race,Asian Peoples,Asian Persons,Asiatic Races,Mongoloid Races,People, Asian,Person, Asian,Race, Asiatic,Race, Mongoloid
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular

Related Publications

Hua Jin, and Xiaoyun Lu, and Jing Ni, and Jinfang Sun, and Bin Gu, and Bo Ding, and Haixia Zhu, and Chao Ma, and Mengjing Cui, and Yuling Xu, and Zhengdong Zhang, and Martin Lercher, and Jian Chen, and Na Gao, and Shizhi Wang
January 2018, Cancer control : journal of the Moffitt Cancer Center,
Hua Jin, and Xiaoyun Lu, and Jing Ni, and Jinfang Sun, and Bin Gu, and Bo Ding, and Haixia Zhu, and Chao Ma, and Mengjing Cui, and Yuling Xu, and Zhengdong Zhang, and Martin Lercher, and Jian Chen, and Na Gao, and Shizhi Wang
February 2017, Future oncology (London, England),
Hua Jin, and Xiaoyun Lu, and Jing Ni, and Jinfang Sun, and Bin Gu, and Bo Ding, and Haixia Zhu, and Chao Ma, and Mengjing Cui, and Yuling Xu, and Zhengdong Zhang, and Martin Lercher, and Jian Chen, and Na Gao, and Shizhi Wang
November 2012, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society,
Hua Jin, and Xiaoyun Lu, and Jing Ni, and Jinfang Sun, and Bin Gu, and Bo Ding, and Haixia Zhu, and Chao Ma, and Mengjing Cui, and Yuling Xu, and Zhengdong Zhang, and Martin Lercher, and Jian Chen, and Na Gao, and Shizhi Wang
July 2011, Gynecologic oncology,
Hua Jin, and Xiaoyun Lu, and Jing Ni, and Jinfang Sun, and Bin Gu, and Bo Ding, and Haixia Zhu, and Chao Ma, and Mengjing Cui, and Yuling Xu, and Zhengdong Zhang, and Martin Lercher, and Jian Chen, and Na Gao, and Shizhi Wang
January 2016, PloS one,
Hua Jin, and Xiaoyun Lu, and Jing Ni, and Jinfang Sun, and Bin Gu, and Bo Ding, and Haixia Zhu, and Chao Ma, and Mengjing Cui, and Yuling Xu, and Zhengdong Zhang, and Martin Lercher, and Jian Chen, and Na Gao, and Shizhi Wang
October 2025, Nan fang yi ke da xue xue bao = Journal of Southern Medical University,
Hua Jin, and Xiaoyun Lu, and Jing Ni, and Jinfang Sun, and Bin Gu, and Bo Ding, and Haixia Zhu, and Chao Ma, and Mengjing Cui, and Yuling Xu, and Zhengdong Zhang, and Martin Lercher, and Jian Chen, and Na Gao, and Shizhi Wang
April 2022, BMC cardiovascular disorders,
Hua Jin, and Xiaoyun Lu, and Jing Ni, and Jinfang Sun, and Bin Gu, and Bo Ding, and Haixia Zhu, and Chao Ma, and Mengjing Cui, and Yuling Xu, and Zhengdong Zhang, and Martin Lercher, and Jian Chen, and Na Gao, and Shizhi Wang
November 2014, Scandinavian journal of immunology,
Hua Jin, and Xiaoyun Lu, and Jing Ni, and Jinfang Sun, and Bin Gu, and Bo Ding, and Haixia Zhu, and Chao Ma, and Mengjing Cui, and Yuling Xu, and Zhengdong Zhang, and Martin Lercher, and Jian Chen, and Na Gao, and Shizhi Wang
February 2011, International journal of immunogenetics,
Hua Jin, and Xiaoyun Lu, and Jing Ni, and Jinfang Sun, and Bin Gu, and Bo Ding, and Haixia Zhu, and Chao Ma, and Mengjing Cui, and Yuling Xu, and Zhengdong Zhang, and Martin Lercher, and Jian Chen, and Na Gao, and Shizhi Wang
March 2012, DNA and cell biology,
Copied contents to your clipboard!